NCT06343974Recruiting
Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics
Source: ClinicalTrials.gov · Last updated 28 Nov 2025
Brief summary (registry, in English)
The goal of this observational study is to compare fetal liver ultrasound radiomics between pregnancies complicated by type 1 diabetes and healthy controls. The main questions it aims to answer are: * Are fetal liver ultrasound radiomic features reproducible? * Does fetal liver ultrasound radiomics differ between pregnancies complicated by type 1 diabetes and healthy controls? Participants will undergo ultrasound examination to collect ultrasound data for the analyses.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 25 Mar 2024
- Start date
- 11 Oct 2024
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Turku University Hospital
- Diseases
- Type 1 diabetes
- NCT number
- NCT06343974
What you commit to
- Study type: Observational
- Planned participants: 60
- From 11 Oct 2024 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Verified fetal infection (e.g. cytomegalovirus, toxoplasma, hepatitis B and C), excluding bacterial infection due to intrapartum chorioamnionitis
- Placenta accreta spectrum disorder
- Major maternal medical condition requiring systemic pharmacological treatment, other than non-severe hypertension, hypothyroidism, asthma, mild psychiatric disorders, etc.
Other
- Major fetal chromosomal, genetic, or structural anomaly
- Fetal growth restriction, or birth weight \< 10th centile
- Birth weight \> 90th centile or polyhydramnios in the controls
- Non-reassuring fetal status requiring immediate treatment, or intrauterine fetal demise
- Alcohol or tobacco use, or substance abuse in pregnancy
Who the study is looking for
- Age between 18-45 years
- Capable to give an informed consent
- Singleton pregnancy
- Planning to deliver in Turku University Hospital
- Maternal BMI \< 40
- Gestational age should be confirmed by first trimester ultrasound
- Normal oral glucose tolerance test (OGTT) at 24-28 gestational weeks in controls
Age in the registry: 18 years to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Turku University Hospital Coordinator of this site? Confirm its status | Turku | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.